Type I Collagen Matrix with Polyhexylmethylene Biguanide in a Chronic Lower Extremity Wound
Main Article Content
Keywords
Chronic wounds, skin substitute, collagen matrix, antimicrobial dressing
Abstract
Chronic wounds pose a significant healthcare challenge, affecting millions of individuals and incurring substantial healthcare costs. In this case study, we present the successful treatment of a chronic lower extremity wound in an 80-year-old female using PuraPly™, a Type I collagen matrix embedded with polyhexylmethylene biguanide (PHMB). The patient initially sustained the injury, which had become infected and resistant to conventional treatments. After applying PuraPly™, the wound showed rapid improvement, ultimately resulting in complete closure. Our findings highlight the utility of PuraPly™ as an effective intervention for chronic wounds, thereby improving treatment outcomes and the quality of life for these patients.
References
2. Wilgus TA, Roy S, McDaniel JC. Neutrophils and Wound Repair: Positive Actions and Negative Reactions. Adv Wound Care (New Rochelle). Sep 2013;2(7):379-388. doi:10.1089/wound.2012.0383
3. Sen CK. Human Wound and Its Burden: Updated 2020 Compendium of Estimates. Adv Wound Care (New Rochelle). May 2021;10(5):281-292. doi:10.1089/wound.2021.0026
4. Nussbaum SR, Carter MJ, Fife CE, et al. An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds. Value Health. Jan 2018;21(1):27-32. doi:10.1016/j.jval.2017.07.007
5. Vogt TN, Koller FJ, Santos PND, Lenhani BE, Guimaraes PRB, Kalinke LP. Quality of life assessment in chronic wound patients using the Wound-QoL and FLQA-Wk instruments. Invest Educ Enferm. Oct 2020;38(3)doi:10.17533/udea.iee.v38n3e11
6. Carpenter S DS, Fitzgerald R, et al. Expert Recommendations for Optimizing Outcomes in the Management of Biofilm to Promote Healing of Chronic Wounds. Wounds: a compendium of clinical research and practice. 06/01 2016;28(6 Suppl):S1-S20.
7. Bain MA, Koullias GJ, Morse K, Wendling S, Sabolinski ML. Type I collagen matrix plus polyhexamethylene biguanide antimicrobial for the treatment of cutaneous wounds. J Comp Eff Res. Jul 2020;9(10):691-703. doi:10.2217/cer-2020-0058
8. Muller G, Kramer A, Schmitt J, Harden D, Koburger T. Reduced cytotoxicity of polyhexamethylene biguanide hydrochloride (PHMB) by egg phosphatidylcholine while maintaining antimicrobial efficacy. Chem Biol Interact. Apr 25 2011;190(2-3):171-8. doi:10.1016/j.cbi.2011.02.024
9. Davis SC, Gil J, Solis M, et al. Antimicrobial effectiveness of wound matrices containing native extracellular matrix with polyhexamethylene biguanide. Int Wound J. Jan 2022;19(1):86-99. doi:10.1111/iwj.13600
10. Khansa I, Schoenbrunner AR, Kraft CT, Janis JE. Silver in Wound Care-Friend or Foe?: A Comprehensive Review. Plast Reconstr Surg Glob Open. Aug 2019;7(8):e2390. doi:10.1097/GOX.0000000000002390
11. Melnychuk I, Servetnyk I, Kosnik N. Extracellular Matrix-Based Collagen Dressings for Scalp Repair Following Mohs Micrographic Surgery. Cutis. May 2023;111(5):E33-E35. doi:10.12788/cutis.0796
12. Ray K, Khajoueinejad N, Park S, Chan M, Lee J, Lantis JC, 2nd. The Evidence for Antimicrobial and Hard to Infect Regenerative Matrices. Surg Technol Int. Dec 6 2021;39:75-82. doi:10.52198/21.STI.39.WH1476
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.